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Abstract
Purpose: In this paper, we evaluate the dosimetric differences between absorbeddose to water and absorbed dose to medium in Monte Carlo (MC)-basedcalculations used for radiation therapy treatment plans. Methods: Thirty-fourtreated Head and Neck simultaneously integrated boost cases were analyzedretrospectively. All of them were planned by Monaco treatment planning system(TPS), calculated and reviewed on absorbed dose to medium (Dm) calculations andtreated in Elekta Versa HD LINAC. Absorbed dose to medium Dm was converted toabsorbed dose to water Dw in Monaco treatment planning system using theprocedure based on stopping power ratios and the Bragg-Gray cavity theory.Dosimetric parameters were then compared and analyzed with respect toabsorbed dose to medium (Dm) calculations for multiple planning target volumes(PTVs) and critical organs such as brainstem, spinal cord, left and right lens, leftand right parotids, larynx, left and right middle ear and lips. Results: It was foundthat mean and minimum Dw (i.e. Dw mean and Dw min) of organs at risk did not differmuch (hardly differing by 0.8-2%) with respect to those of the absorbed dose tomedium. However maximum Dw (i.e. Dw max) in case of lips, left and right middle earwere found to differ more than 4% with respect to Dm max. For serial organsbrainstem and spinal cord, maximum dose Dw maxwere found to vary around 1%and 2%, respectively, with respect to absorbed dose to medium dose calculation. Incase of PTVs, the mean percentages variation of Dw minand Dw meanwere found to beless than 1 %, although the variation of maximum Dwwas found to be high around5-7% with respect to that of Dm. Conclusion: The comparative analysis ofdosimetric parameters in the present study shows that the selection of either Dm orDw in Monaco planning system is less likely to produce any significant clinical effectin tumor control and to the damage of organs at risk.
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1. IntroductionMonte Carlo (MC)- based calculations algorithms areconsidered most accurate over the conventional andeven more recent model- based algorithms used in theradiation therapy treatment plans1-7. Despite its provenaccuracy, MC-based-planning has been clinicallypossible only recently due to the improvement in bothcomputer hardware capabilities and improved MCcodes. American association of Physicists in Medicine(AAPM) Task Group-105 (TG-105) has discussedcritically the issues associated with clinicalimplementation of Monte- Carlo-based photon andelectron external beam treatment planning1. One of the
issues which remains debatable is whether one shoulduse absorbed dose-to-water Dw or absorbeddose-to-medium Dm for dose calculations, prescriptionand evaluation when using MC based treatmentplanning system (TPS).Conventional dose calculations for photon beamradiation therapy typically report the absorbeddose-to-water Dw1,6,8. This is due to the fact thathistorically clinical experiences are derived based on Dw.Furthermore, the doses reported in clinical trials andhence the therapeutic and normal tissue tolerance doses
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are based on Dw. The accelerator and ionization chambercalibration protocols are also based on Dw9. The absolutedose measurements, input data used for TPScommissioning are generally dose profiles and outputfactors measured in water phantoms and specified interms of absorbed dose to water Dw. However, MC basedalgorithms perform calculations for absorbed dose tomedium instead of absorbed dose to water. Since theparticle transport simulations occur in materialsrepresentation of patient media, the absorbed dose isspecified to the patient medium Dm10-16. For comparisonof results and their clinical significance in radiationtherapy treatment plans, Dm is converted to Dw by theprocedure developed by Siebers et al.8 using stoppingpower ratios, based upon the Bragg-Gray cavity theoryfor MC-based calculations. For megavolt-age photonbeams, the difference between Dw and Dm for tissueswith densities near 1.0 g/cm3 is small (1−2%). However,for higher density materials, such as cortical bone, thedifference can be as large as 15% since the stoppingpowers of water and that of higher-density materialsdiffer more significantly1,8. Therefore, there is asystematic difference between the dose computed usingconventional analytical algorithms and MC simulation.Any significant differences between Dw and Dm mightlead to the change of dose prescriptions in order tomaintain consistent radio therapy outcomes8,17. Aclinical decision has to be made during radiotherapytreatment planning as to whether one should prescribethe dose using Dm or the converted Dw18.Several studieshave reported dosimetric difference between Dw and Dmbased plans for different clinical cases in variousplanning systems19,20. Dogan et al.21demonstrated thatconverting Dm to Dw in MC- calculated IMRT plansintroduces a systematic error of up to 5.8% for head andneck tumors and 8.0% for prostate cases. However,similar studies for head and neck VMAT cases based onMC-calculated treatment plans using Monaco TPS havenot yet been reported. In the present study, we evaluatethe dosimetric difference between absorbeddose-to-water and absorbed dose-to-medium in theMC-based dose calculation method in the radiationtherapy treatment planning for head & neck VMAT casesand analyze its clinical significance.
2. Methods and Materials
2.1. Patient SelectionA total of 34 head and neck cases with multiple PTVs ofdifferent prescriptions were taken for analysis. Out of 34cases, 28 cases had 3 PTVs and remaining 6 cases had 2PTVs. Patient total prescription details are given in theTable 1. All patients were treated using Elekta Versa HDLinear Accelerator (Elekta Ltd, Crawley, UK) which isequipped with Agility Beam limiting Device. Mosaiq
version (IMPAC Medical systems Inc, Sunnyvale, USA)was used as record and verifying system.
Table 1: Prescription details of patient casesNo of Patients 34Case Head & Neck VMAT3 PTVs cases 282 PTVs cases 6PTV I 6930 cGy – 34 casesPTV II(Total - 34Cases) 6600 cGy- 12 cases;5940 cGy- 4cases6300 cGy- 13cases; 6434 cGy- 5 casesPTV III(Total - 28Cases) 5940 cGy- 5 cases; 5610 cGy-16 cases5775 cGy- 4cases; 5710 cGy- 3 cases
2.2. Treatment Planning3D CT scans of slice thickness of 3 mm were acquiredusing Philips Brilliance CT scanner with patient insupine position. Thermoplastic moulds are used forimmobilization of patients. Monaco treatment planningsystem (Elekta, Crawley, UK) version 5.0 was used forVMAT planning using 6MV photon beams.Monaco treatment planning system uses the Monte Carlodose calculation algorithm for VMAT dosecalculations. The system provides options either to useabsorbed dose to water Dw or absorbed dose to mediumDm mode for treatment dose calculation, prescriptionand evaluation. Here we used the Monaco TPS in whichwe perform MC-based calculation for absorbed dose tomedium Dm. Then we evaluated the absorbed dose towater Dw in Monaco TPS from the MC calculated Dmusing stopping power ratio based on Bragg Gray Cavitytheory8,22. Thus the clinically approved and treated caseswere all specified in terms of absorbed dose to medium,which were then converted to dose to waterspecification and compared with the treated plan.Minimum segment width assigned was taken to be 0.5cm. Grid size and calculation accuracy were set to 0.3 cmand 3% percent per control point, respectively.
2.3. Plan AnalysisThe dose-volume histograms (DVHs) of both the planscalculated for Dm and Dwwere generated in the MonacoTPS. Treatment plans were evaluated for variousdosimetric parameters. The parameters analyzed wereMaximum dose Dmax, Minimum dose Dmin, Mean DoseDmean for organs at risk and those analyzed for PTVs areDmax, Dmin, Dmean and percentage volume covered by 95%prescribed dose D95%. Cumulative dose volumehistogram of one of the patients representing both Dmand Dw calculation is shown in figure 1. Ratios ofabsorbed dose to water to absorbed dose to mediumDw/Dm were computed for Dmax, Dmin, Dmean and forpercentage volume covered by 95% prescribed doseD95% (PTVs). The ratios Dw/Dmwere plotted for criticalorgans at risks and for PTVs.
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Figure 1: DVHs and isodose distributions of Dw and Dmbased plans of one of the cases under study.
The relative percentage difference ∆ between thedosimetric parameters Dw and Dm based plans for eachcase was calculated using the relation
( ) 100 % ,wx mx
mx
D D
D
     
where is the corresponding dosimetric parameter(mean dose, maximum dose, etc.). The mean and thestandard deviation of the percentage variations ofcorresponding dosimetric parameters corresponding toall patient cases were calculated.
3. ResultsThe percentage variation of Dwwith respect to Dm andthe respective standard deviation for all critical organswere obtained as shown in the Table 2. The variations ofratio Dw/Dm for Maximum dose Dmax, Minimum dose Dmin,
Mean Dose Dmean for critical organs at risk are shown inthe Figure 2. The mean percentage variation of Dw minwith respect to Dm min for brainstem, spinal cord, left andright lens, left and right parotids, larynx, left & rightmiddle ear and lips were found to be 0.80, 1.13, 0.80,0.85, -0.43, -0.61, 0.84, 2.23, 2.16, and -0.49,respectively. The corresponding values of Dw mean withrespect to Dm mean for brainstem, spinal cord, left andright lens, left & right parotids, larynx, left and rightmiddle ear and lips were obtained as 0.95, 1.10, 0.77,0.77, 0.30, 0.30, 0.45, 1.80, 1.86, 1.91 and 0.77,respectively. However, the mean percentage variation ofDw max with respect to Dm max for brainstem, spinal cord,left and right lens, left and right parotids, larynx, left &right middle ear and lips were found to be 1.06, 1.95,0.60, 0.61, 0.62, 0.52, 1.24, 4.70, 4.02 and 4.35,respectively. The plots showing the variation of ratioDw/Dm for Dmax, Dmin and Dmean of critical organs at riskare shown in Figure 2.
4 Gopal et al.: Dose-to-medium vs. Dose-to-water: H&N VMAT cases using Monaco TPS International Journal of Cancer Therapy and Oncology
www.ijcto.org
©Gopal et al. ISSN 2330-4049
Table 2: Percentage variation ± standard deviation of Dw with respect to Dm for critical organs at riskOrgans at risk ( ) 100 %wmin mmin
mmin
D D
D
    
( ) 100 %wmax mmax
mmax
D D
D
    
( ) 100 %wmean mmean
mmean
D D
D
    Brain stem 0.80±0.23 1.06±0.51 0.95±0.07Spinal cord 1.13±1.16 1.95±1.15 1.10±0.13LT lens 0.80±0.26 0.60±0.32 0.77±0.29RT lens 0.85±0.31 0.61±0.35 0.77±0.29Parotid LT -0.43±0.64 0.62±0.99 0.30±0.38Parotid RT -0.61±0.60 0.52±0.70 0.30±0.39Larynx 0.84±0.83 1.24±0.82 0.45±0.28Middle ear LT 2.23±3.47 4.70±2.76 1.80±1.38Middle ear RT 2.16±3.64 4.02±2.48 1.86±1.43Lips -0.49±0.73 4.35±3.32 1.91±1.25
Figure 2: Variations of ratio Dw/Dm for Dmax, Dmin, Dmean for critical organs at risk.
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Table 3: Percentage variation ± standard deviation of Dw with respect to Dm for multiple planning target volumes.PTVs ( ) 100%wmin mmin
mmin
D D
D
    
( ) 100%wmax mmax
mmax
D D
D
    
( ) 100%wmean mmean
mmean
D D
D
    
 95%  95%
 95% 
( ) 100%Dw Dm
Dm
V V
V
    PTV I 0.97 ±2.01 4.95 ±5.29 0.76 ±0.37 0.07 ±0.20PTV II 0.61 ±1.81 6.37 ±4.75 0.88 ±0.27 0.48 ±0.30PTVIII -0.35 ±1.42 6.38 ±4.86 0.49 ±0.37 -0.04 ±0.20
Figure 3: Variations of ratio Dw/Dm for Maximum dose Dmax, Minimum dose Dmin, Mean Dose Dmean for multiple PTVs.The percentage variations of Dw with respect to Dm forPTVs are shown in Table 3. The mean percentagevariation of Dw min with respect to Dm min for PTV I, PTV IIand PTV III were obtained as 0.97, 0.61 and -0.35,respectively; The mean percentage variation of Dw meanwith respect to Dm mean were found to be 0.76, 0.88 and0.49 respectively. However, the mean percentagevariation of Dw max with respect to Dm maxwere found tobe 4.95, 6.37, and 6.38 respectively. Plots showing thevariations of ratio Dw/Dm for Maximum dose Dmax,Minimum dose Dmin, Mean Dose Dmean of PTV I, PTV II andPTV III are shown in Figure 3.
4. DiscussionIn clinical evaluation and dose calculation methodsadopted for radiation therapy treatment plans, it stillremains unsettled whether one should considerdose-to-medium Dm in place of dose-to-water Dw. Thereare strong arguments in favor of both. In dosimetry,when using ionization chamber, one measures thecharge produced in air then converts the measuredcharge to dose to water. So, it will be more sensible toconvert dosimeter readings and results from dosecalculation algorithms to Dm for comparison with MonteCarlo results. Also, converting Dm to Dw might bringadditional uncertainty and complexity. However, sincedosimetry calibration protocols are based on Dw
6 Gopal et al.: Dose-to-medium vs. Dose-to-water: H&N VMAT cases using Monaco TPS International Journal of Cancer Therapy and Oncology
www.ijcto.org
©Gopal et al. ISSN 2330-4049
standard (AAPM TG-51 1999)23, conversion of all dosecalculation results to this standard seems reasonable.Furthermore, the biological indices (NTCP, TCP etc.) aregiven in terms of Dw. Ma et al.24 suggested in favor ofDm-based approach for radiation therapy doseprescription, treatment plan evaluation and planoutcome consistent with previous radiation therapyexperience. On the other hand, Walter et al.25 suggestedthat the selection of Dw in place of Dm in MC treatmentplans is more reasonable, since Dw provides betterestimate of dose to sensitive skeletal tissues. The AAPMTG 105 report recommends that in TPS one can availboth the options (Dm and Dw) for dose reporting1. Suchan approach helps to have a comparative dosimetricanalysis leading to appropriate dose prescription in TPSand thus revealing the clinical significance of the methodused.In the present study, it was observed that Dw min, Dw meanand volume of Dw 95% for PTVs did not vary much(0.5-2%), whereas Dw max varied significantly around5-7% which may have some biological effect likenecrosis in tumor. Since maximum dose escalation maybe acceptable in most PTV cases, its variation may not beclinically that significant and may not affect the tumorcontrol. For critical organs at risk, the variation of Dw meanfor parallel organs like left and right parotids, larynx, left& right middle ear and lips were found to be small(1-2%). But, maximum doses for lips, left and rightmiddle ear in Dwbased calculation were found to differmore than 4%. Since only mean dose is clinicallysignificant for parallel organs, present analysis showsthat the choice of Dw or Dm based calculation, does nothave any significant clinical effect. In case of serialorgans like spinal cord and brainstem, the meanpercentage variation of Dw max with respect to Dmmax wasfound less around 1-2%. For Lenses, it was varying onlyabout 0.6%. Hence, it looks like that in plan evaluationand implementation whether one uses Dw or Dm basedcalculations, the clinical endpoint almost remainsunaffected. Further studies encompassing larger samplesize of patients and more sites may reveal more aboutthe clinical significance of using Dw or Dm in such MCbased radiation therapy treatment planning systems.
5. ConclusionThe present study evaluates the dosimetric differencesbetween Dm or Dw based calculations for head & neckVMAT cases in the radiation therapy treatment planningsystem (Monaco TPS) using the Monte Carlo-based dosecalculation algorithms. The analysis of dosimetricparameters indicates that the selection of either Dm orDw based calculations in the Monaco planning system isless likely to produce any significant clinical effect intumor control and damage to organs at risk. However,there is appreciable increase in the maximum dosescalculated based on Dw compared to Dm max in targetwhich may be clinically desirable in PTVs.
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